The authors of the study hope it will highlight the importance of self-reported symptoms and risk factors. They urge people to understand the tools that can allow for faster and easier assessment in populations where sleep studies are not readily accessible such as remote or rural locations.
“While it is important that at some point in a patient’s management they do take part in an overnight sleep study to confirm their diagnosis and determine best treatment options, the reliability of self-reported symptoms could see more patients diagnosed with COMISA and sooner,” said study lead author Dr. Alexander Sweetman.
Obstructive sleep apnea (OSA) and insomnia are two of the most common sleep disorders which occur in 10 – 30% of the general population. However, in many patients, the conditions can occur at the same time, which is called co-morbid insomnia and sleep apnea (COMISA).
Previous studies have shown that almost 50% of people with OSA have clinically significant insomnia and 30 – 40% of people with chronic insomnia have OSA. Both conditions are independently associated with reduced quality of life and high healthcare use.
However, this study also outlines how when combined, the conditions may lead to an increased risk of mental health issues, less productivity, greater cases of cardiovascular disease, and even death. It is vital that people take steps to ensure they get quality sleep to help with overall health.
Maintaining Sleep Quality
Sleep Sure Plus is designed to help promote optimal sleep and restfulness through a variety of ingredients. One of the most important ingredients included in this unique formula is melatonin.
Melatonin is a hormone that is essential for the regulation of the circadian rhythm (the internal clock of the body). Sleep Sure Plus also contains valerian, one of the best natural ingredients for promoting rest and relaxation. These two essential ingredients are joined by another 6, which all work together to provide a better quality of sleep.